cancer clinical trials for Cellular Therapy Support Service - CAR-T (ONC)

10 Cellular Therapy Support Service - CAR-T (ONC) clinical trials found. View a list of all cancer clinical trial types.

• Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel (CTL019; Kymriah®)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 1 study evaluating SC291, a hypoimmune allogeneic CD19-directed CAR T cell therapy, in relapsed and/or refractory B-cell malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Protocol (EAP) For Subjects Receiving Idecabtagene Vicleucel That Is Nonconforming For Commercial Release

  Current Status: Open

  View links and contact information related to this clinical trial

• A PHASE 1 DOSE ESCALATION AND EXPANDED COHORT STUDY OF P-MUC1C-ALLO1 IN ADULT SUBJECTS WITH ADVANCED OR METASTATIC SOLID TUMORS

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Protocol (EAP) For Patients Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release

  Current Status: Open

  View links and contact information related to this clinical trial

• Intermediate-Size Population Expanded Access Program (EAP) for cilta-cel Out-of-Specification (OOS) in Patients with Multiple Myeloma

  Current Status: Open

  View links and contact information related to this clinical trial

• Low Dose Radiation as Bridging Therapy for Lisocabtagene Maraleucel in Relapsed B-Cell Non-Hodgkin Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 2, Multi-Cohort, Open-Label, Multicenter Study to Determine the Efficacy and Safety of bb2121 in Subjects wth Relapsed and Refractory Multiple Myeloma and in Subjects with High-Risk Multiple Myeloma Having Progressed Within One Year of Initial Treatment (KarMMa-2)

  Current Status: Open

  View links and contact information related to this clinical trial